Cempra announces allowance of US patent to taksta loading dose formulation
With the possibility for extension, the patent entitled ‘Fusidic Acid Dosing Regimens for Treatment of Bacterial Infections’ protects US market exclusivity to 2029. Cempra chief executive officer Prabhavathi